"

From 2012e.igem.org

Revision as of 14:54, 29 April 2012 (view source) HOPEBV (Talk | contribs) ← Older edit		Revision as of 15:50, 20 October 2012 (view source) Ptmvanboheemen (Talk | contribs) (→Source Data) Newer edit →
Line 1:		Line 1:
	===Source Data===		===Source Data===
-	Describe, summarize and link to any data sources you used, including public datasets, bibliographies, news articles, etc. Do not post any proprietary data from private or closed databases, but describe the kind of insight you gleaned from them.	+	Reports:
		+	*World Malaria Report - Burkina Faso Malaria Profile
		+	*WHO - Guidlines for the treatment of Malaria
		+	*WHO - Malaria Case Management
		+	*WHO - Malaria Rapid Diagnostic Test Performance
		+	*WHO - Selecting and procuring Rapid Diagnostic Tests for Malaria
		+	*WHO - Universal Access to Malaria Diagnostic Testing
		+	*WHO - Establisment of PCR Laboratories in Developing Countries
		+	*UNITAID - Malaria Diagnostic Technology Landscape
		+	*Roll Back Malaria - Key Facts Figures and Strategies
		+	*International Finance Corporation - The Next 4 Billion
-	This section is a very important because it helps future teams, and contributes to the public commons and knowledge about Synthetic Biology.	+	Websites:
		+	*Foundation for Innovative New Diagnostics
		+	*Gates Foundation

---

Revision as of 15:50, 20 October 2012

Source Data

Reports:

• World Malaria Report - Burkina Faso Malaria Profile
• WHO - Guidlines for the treatment of Malaria
• WHO - Malaria Case Management
• WHO - Malaria Rapid Diagnostic Test Performance
• WHO - Selecting and procuring Rapid Diagnostic Tests for Malaria
• WHO - Universal Access to Malaria Diagnostic Testing
• WHO - Establisment of PCR Laboratories in Developing Countries
• UNITAID - Malaria Diagnostic Technology Landscape
• Roll Back Malaria - Key Facts Figures and Strategies
• International Finance Corporation - The Next 4 Billion

Websites:

• Foundation for Innovative New Diagnostics
• Gates Foundation